These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 29981090)

  • 41. The effects of stimulant and non-stimulant medications on the autonomic nervous system (ANS) functioning in people with ADHD: A systematic review and meta-analysis.
    Idrees I; Bellato A; Cortese S; Groom MJ
    Neurosci Biobehav Rev; 2023 Jan; 144():104968. PubMed ID: 36427764
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of stimulants on sleep characteristics in children with attention deficit/hyperactivity disorder.
    O'Brien LM; Ivanenko A; Crabtree VM; Holbrook CR; Bruner JL; Klaus CJ; Gozal D
    Sleep Med; 2003 Jul; 4(4):309-16. PubMed ID: 14592303
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cardiovascular effects of longer-term, high-dose OROS methylphenidate in adolescents with attention deficit hyperactivity disorder.
    Hammerness P; Wilens T; Mick E; Spencer T; Doyle R; McCreary M; Becker J; Biederman J
    J Pediatr; 2009 Jul; 155(1):84-9, 89.e1. PubMed ID: 19394037
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Short-term effects of lisdexamfetamine dimesylate on cardiovascular parameters in a 4-week clinical trial in adults with attention-deficit/hyperactivity disorder.
    Adler LA; Weisler RH; Goodman DW; Hamdani M; Niebler GE
    J Clin Psychiatry; 2009 Dec; 70(12):1652-61. PubMed ID: 20141706
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Meta-analysis of increased heart rate and blood pressure associated with CNS stimulant treatment of ADHD in adults.
    Mick E; McManus DD; Goldberg RJ
    Eur Neuropsychopharmacol; 2013 Jun; 23(6):534-41. PubMed ID: 22796229
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Stimulant treatment and injury among children with attention deficit hyperactivity disorder: an application of the self-controlled case series study design.
    Raman SR; Marshall SW; Haynes K; Gaynes BN; Naftel AJ; Stürmer T
    Inj Prev; 2013 Jun; 19(3):164-70. PubMed ID: 23143347
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A controlled study of autonomic nervous system function in adults with attention-deficit/hyperactivity disorder treated with stimulant medications: results of a pilot study.
    Schubiner H; Hassunizadeh B; Kaczynski R
    J Atten Disord; 2006 Nov; 10(2):205-11. PubMed ID: 17085631
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder: results from a population-based study.
    Barbaresi WJ; Katusic SK; Colligan RC; Weaver AL; Leibson CL; Jacobsen SJ
    J Dev Behav Pediatr; 2014 Sep; 35(7):448-57. PubMed ID: 25180895
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Abnormal executive function in attention deficit hyperactivity disorder: the effect of stimulant medication and age on spatial working memory.
    Barnett R; Maruff P; Vance A; Luk ES; Costin J; Wood C; Pantelis C
    Psychol Med; 2001 Aug; 31(6):1107-15. PubMed ID: 11513378
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adult attention-deficit/hyperactivity disorder treatment and cardiovascular implications.
    Hammerness PG; Surman CB; Chilton A
    Curr Psychiatry Rep; 2011 Oct; 13(5):357-63. PubMed ID: 21698412
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Empathy and Facial Expression Recognition in Children With and Without Attention-Deficit/Hyperactivity Disorder: Effects of Stimulant Medication on Empathic Skills in Children with Attention-Deficit/Hyperactivity Disorder.
    Gumustas F; Yilmaz I; Yulaf Y; Gokce S; Sabuncuoglu O
    J Child Adolesc Psychopharmacol; 2017 Jun; 27(5):433-439. PubMed ID: 28332851
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of long-term methylphenidate use on growth and blood pressure: results of the German Health Interview and Examination Survey for Children and Adolescents (KiGGS).
    McCarthy S; Neubert A; Man KKC; Banaschewski T; Buitelaar J; Carucci S; Coghill D; Danckaerts M; Falissard B; Garas P; Häge A; Hollis C; Inglis S; Kovshoff H; Liddle E; Mechler K; Nagy P; Rosenthal E; Schlack R; Sonuga-Barke E; Zuddas A; Wong ICK
    BMC Psychiatry; 2018 Oct; 18(1):327. PubMed ID: 30305167
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Psychotropic medication use in a population of children who have attention-deficit/hyperactivity disorder.
    Guevara J; Lozano P; Wickizer T; Mell L; Gephart H
    Pediatrics; 2002 May; 109(5):733-9. PubMed ID: 11986429
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fundamental movement skills and children with attention-deficit hyperactivity disorder: peer comparisons and stimulant effects.
    Harvey WJ; Reid G; Grizenko N; Mbekou V; Ter-Stepanian M; Joober R
    J Abnorm Child Psychol; 2007 Oct; 35(5):871-82. PubMed ID: 17503174
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Executive function and attention deficit hyperactivity disorder: stimulant medication and better executive function performance in children.
    Kempton S; Vance A; Maruff P; Luk E; Costin J; Pantelis C
    Psychol Med; 1999 May; 29(3):527-38. PubMed ID: 10405075
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Blood Pressure, Heart Rate, and CNS Stimulant Medication Use in Children with and without ADHD: Analysis of NHANES Data.
    Hailpern SM; Egan BM; Lewis KD; Wagner C; Shattat GF; Al Qaoud DI; Shatat IF
    Front Pediatr; 2014; 2():100. PubMed ID: 25285304
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term cardiovascular effects of mixed amphetamine salts extended release in adults with ADHD.
    Weisler RH; Biederman J; Spencer TJ; Wilens TE
    CNS Spectr; 2005 Dec; 10(12 Suppl 20):35-43. PubMed ID: 16344839
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
    Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
    Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacotherapy for incident attention-deficit/hyperactivity disorder: practice patterns and quality metrics.
    Bussing R; Narwaney KJ; Winterstein AG; Newton DA; DeBar L; Boscarino JA; Toh S; Pawloski P; Nordin JD; Herrinton LJ; Mason D; Daley MF
    Curr Med Res Opin; 2014 Aug; 30(8):1687-99. PubMed ID: 24635013
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Spatial attentional bias as a marker of genetic risk, symptom severity, and stimulant response in ADHD.
    Bellgrove MA; Barry E; Johnson KA; Cox M; Dáibhis A; Daly M; Hawi Z; Lambert D; Fitzgerald M; McNicholas F; Robertson IH; Gill M; Kirley A
    Neuropsychopharmacology; 2008 Sep; 33(10):2536-45. PubMed ID: 18046306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.